News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
179,470 Results
Type
Article (12719)
Company Profile (24)
Press Release (166727)
Section
Business (61815)
Career Advice (270)
Deals (11927)
Drug Delivery (32)
Drug Development (20949)
Employer Resources (38)
FDA (2608)
Job Trends (3788)
News (95141)
Policy (6904)
Tag
Academia (987)
Africa (220)
Alliances (14885)
Alzheimer's disease (428)
Antibody-drug conjugate (ADC) (25)
Approvals (2605)
Arizona (30)
Artificial intelligence (37)
Asia (10630)
Australia (1885)
Bankruptcy (151)
Best Places to Work (2687)
Biotechnology (20)
Breast cancer (24)
C2C Services and Suppliers (13571)
California (710)
Canada (457)
Cancer (194)
Career advice (226)
Cell therapy (50)
China (31)
Clinical research (16238)
Collaboration (72)
Colorado (33)
Connecticut (30)
COVID-19 (716)
Cystic fibrosis (41)
Data (143)
Diabetes (21)
Diagnostics (1525)
Drug pricing (25)
Earnings (22949)
Employer resources (32)
Europe (24980)
Events (17551)
Executive appointments (73)
FDA (2677)
Florida (94)
Funding (177)
Gene therapy (31)
GLP-1 (167)
Government (1204)
Healthcare (5191)
Hotbed/Location (121722)
Illinois (72)
Indiana (41)
Infectious disease (729)
Inflammatory bowel disease (32)
Interviews (36)
IPO (6364)
Job creations (1121)
Job search strategy (218)
Kansas (28)
Layoffs (166)
Legal (1553)
Liver cancer (20)
Lung cancer (31)
Manufacturing (42)
Maryland (94)
Massachusetts (485)
Medical device (3061)
Medtech (3063)
Mergers & acquisitions (5506)
Metabolic disorders (77)
Minnesota (47)
Neuroscience (478)
New Jersey (167)
New York (240)
NextGen Class of 2024 (2177)
Non-profit (2403)
North Carolina (158)
Northern California (321)
Obesity (43)
Ohio (42)
Opinion (100)
Patents (24)
Pennsylvania (177)
People (17933)
Phase I (5447)
Phase II (7743)
Phase III (4876)
Pipeline (80)
Policy (29)
Postmarket research (433)
Preclinical (2208)
Radiopharmaceuticals (72)
Rare diseases (62)
Real estate (1354)
Regulatory (4394)
Research institute (916)
Resumes & cover letters (43)
Series A (33)
South America (265)
Southern California (295)
Startups (2974)
Texas (76)
United States (2707)
Vaccines (108)
Washington State (74)
Weight loss (31)
Date
Last 7 days (193)
Last 30 days (761)
Last 365 days (11697)
2024 (8845)
2023 (12402)
2022 (16752)
2021 (16993)
2020 (16499)
2019 (13713)
2018 (10671)
2017 (10022)
2016 (8588)
2015 (10244)
2014 (7149)
2013 (5312)
2012 (5603)
2011 (6095)
2010 (5743)
179,470 Results for "novartis venture funds".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Novartis, Versant Launch RNA Kidney Medicines—Focused Borealis
Looking to build on the success of Chinook Therapeutics, founded by Versant in 2019 and acquired by Novartis last year, the companies on Thursday launched Borealis Biosciences with $150 million in funding to develop RNA therapeutics for kidney diseases.
August 22, 2024
·
2 min read
·
Kate Goodwin
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund
J.P. Morgan’s life sciences venture capital arm on Thursday announced it closed its first biotech fund, targeting companies in cardiometabolic disease, immunology, oncology and genetic medicine.
June 14, 2024
·
2 min read
·
Tyler Patchen
Pharm Country
Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech
While the VC fund launched on Monday by Regeneron Pharmaceuticals has an investment mandate that includes healthcare broadly, Regeneron Ventures will lean towards biotechnology, devices, tools and enabling technologies.
April 15, 2024
·
2 min read
·
Tyler Patchen
Approvals
Novartis Pushes Kisqali Into Earlier Stages of Breast Cancer, Nearly Doubles Eligible Patient Population
The FDA’s approval of Kisqali in combination with an aromatase inhibitor allows Novartis to target patients with earlier breast cancer who are at risk of recurrence.
September 18, 2024
·
2 min read
·
Tristan Manalac
Cardiovascular disease
Novartis Plots Leqvio Expansion After Lowering Cholesterol in Phase III Study
Armed with new late-stage data on reducing low-density lipoprotein cholesterol, Novartis is positioning its siRNA therapy Leqvio as a preventive treatment for atherosclerotic cardiovascular disease.
August 29, 2024
·
2 min read
·
Tristan Manalac
Pharm Country
Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund
Elion Therapeutics announced today it has closed a $81 million Series B funding round led by Deerfield Management (“Deerfield”) and the AMR Action Fund. Additional investors include Illinois Ventures.
June 17, 2024
·
4 min read
Startups
BridgeBio Launches GondolaBio With $300M, Transfers Programs to Joint Venture
With the help of third-party investors, the new venture will focus on three genetic and rare diseases: tuberous sclerosis complex, erythropoietic protoporphyria and alpha-A1 antitrypsin deficiency.
August 22, 2024
·
2 min read
·
Tristan Manalac
News
Novartis Canada launches $500,000 funding initiative to improve health equity in Canada
July 9, 2024
·
3 min read
Legal
Novartis Loses Court Case to Block Entresto Generics After FDA Denies Petition
On the heels of the FDA’s denial of its petition, a Delaware district court on Monday handed Novartis another loss in its efforts to keep the market free of Entresto copycats.
August 13, 2024
·
2 min read
·
Tristan Manalac
Earnings
Despite Layoff Announcements, Novartis Beats Q2 Expectations
Novartis’ second-quarter earnings, announced Thursday, show strong performance of its blockbuster drugs, prompting the company to raise its year-end guidance.
July 18, 2024
·
2 min read
·
Tyler Patchen
1 of 17,947
Next
